Both discordant and concordant bone marrow (BM) involvement predict for a poorer outcome independent of the IPI in patients with diffuse large B-cell lymphoma (DLBCL) treated with R-CHOP

被引：0
|
作者：
Sehn, Laurie H. [1 ]
Chhanabhai, Mukesh [2 ]
Singh, Suman [2 ]
Saville, Wayne [3 ]
Matso, Dan [3 ]
Spinelli, John J. [4 ]
Connors, Joseph M. [1 ]
Gascoyne, Randy D. [2 ]
机构：
[1] British Columbia Canc Agcy, Dept Med Oncol, Vancouver, BC, Canada
[2] British Columbia Canc Agcy, Dept Pathol, Vancouver, BC, Canada
[3] Biogen Idec Inc, San Diego, CA USA
[4] British Columbia Canc Agcy, Program Dis Control, Vancouver, BC, Canada
来源：
BLOOD | 2007年 / 110卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1559
引用
收藏
页码：466A / 466A
页数：1
相关论文
共 50 条
  • [1] Impact of Concordant and Discordant Bone Marrow Involvement on Outcome in Diffuse Large B-Cell Lymphoma Treated With R-CHOP
    Sehn, Laurie H.
    Scott, David W.
    Chhanabhai, Mukesh
    Berry, Brian
    Ruskova, Anna
    Berkahn, Leanne
    Connors, Joseph M.
    Gascoyne, Randy D.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (11) : 1452 - 1457
  • [2] Prognostic impact of concordant and discordant cytomorphology of bone marrow involvement in patients with diffuse, large, B-cell lymphoma treated with R-CHOP
    Shim, Hyoeun
    Oh, Jae-Il
    Park, Sang Hyuk
    Jang, Seongsoo
    Park, Chan-Jeoung
    Huh, Jooryung
    Suh, Cheolwon
    Chi, Hyun-Sook
    JOURNAL OF CLINICAL PATHOLOGY, 2013, 66 (05) : 420 - 425
  • [3] Prognostic impact of concordant and discordant bone marrow involvement and cell-of-origin in Korean patients with diffuse large B-cell lymphoma treated with R-CHOP
    Park, Mi-Jung
    Park, Soon-Ho
    Park, Pil-Whan
    Seo, Yiel-Hea
    Kim, Kyung-Hee
    Seo, Ja-Young
    Jeong, Ji-Hun
    Kim, Moon Jin
    Ahn, Jeong-Yeal
    Hong, Junshik
    JOURNAL OF CLINICAL PATHOLOGY, 2015, 68 (09) : 733 - 738
  • [4] Impact of Occult Bone Marrow Involvement on Outcome in Diffuse Large B-Cell Lymphoma Treated with R-CHOP
    Arima, Hiroshi
    Maruoka, Hayato
    Nasu, Koji
    Funayama, Yuki
    Takeda, June
    Yamauchi, Nobuhiko
    Aoki, Kazunari
    Kato, Aiko
    Ono, Yuichiro
    Nagano, Seiji
    Takiuchi, Yoko
    Tabata, Sumie
    Matsushita, Akiko
    Imai, Yukihiro
    Takahashi, Takayuki
    Ishikawa, Takayuki
    BLOOD, 2011, 118 (21) : 685 - 686
  • [5] R-IPI as a predictor of survival in patients with diffuse large cell B-cell lymphoma (DLBCL) treated with R-chop chemotherapy
    Siddiqui, M.
    Johnston, P. B.
    Micallef, I. N.
    Ansell, S. M.
    Colgan, J. P.
    Habermann, T. M.
    Inwards, D. J.
    Markovic, S. N.
    Ristow, K.
    Witzig, T. E.
    Porrata, L. F.
    ANNALS OF ONCOLOGY, 2008, 19 : 146 - 146
  • [6] CONCORDANT BONE MARROW INVOLVEMENT MAINTAINS AN ADVERSE PROGNOSTIC SIGNIFICANCE IN PATIENTS WITH DIFFUSE LARGE B CELL LYMPHOMA TREATED WITH R-CHOP
    Gaudio, F.
    Perrone, T.
    Spina, A.
    Scardino, S.
    Nardelli, G.
    Ingravallo, G.
    Cimmino, A.
    Napoli, A.
    Specchia, G.
    HAEMATOLOGICA, 2012, 97 : 661 - 662
  • [7] MicroRNAs Are Independent Predictors of Outcome in Diffuse Large B-Cell Lymphoma Patients Treated with R-CHOP
    Alencar, Alvaro J.
    Malumbres, Raquel
    Kozloski, Goldi A.
    Advani, Ranjana
    Talreja, Neha
    Chinichian, Shideh
    Briones, Javier
    Natkunam, Yasodha
    Sehn, Laurie H.
    Gascoyne, Randy D.
    Tibshirani, Rob
    Lossos, Izidore S.
    CLINICAL CANCER RESEARCH, 2011, 17 (12) : 4125 - 4135
  • [8] Revised international prognostic index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-Cell lymphoma (DLBCL) treated with rituximab and CHOP (R-CHOP).
    Sehn, LH
    Chhanabhai, M
    Fitzgerald, C
    Gill, K
    Hoskins, P
    Klasa, R
    Savage, K
    Shenkier, T
    Sutherland, J
    Wilson, K
    Gascoyne, RD
    Connors, JM
    BLOOD, 2005, 106 (11) : 147A - 147A
  • [9] Prognostic impact of concordant and discordant bone marrow involvement on diffuse large B-cell lymphoma
    Zuo, Huaqin
    Xie, Xiaoyan
    Sun, Xing
    Shi, Hanxue
    Pei, Xiaoping
    Sun, Mei
    TRANSLATIONAL CANCER RESEARCH, 2024, 13 (10) : 5339 - 5346
  • [10] Prognostic significance of primary extranodal diffuse large B-cell lymphoma (DLBCL) in patients treated with R-CHOP
    Hui, D.
    Proctor, B.
    Donaldson, J.
    Shenkier, T.
    Hoskins, P.
    Klasa, R.
    Savage, K.
    Gascoyne, R.
    Connors, J. M.
    Sehn, L. L.
    ANNALS OF ONCOLOGY, 2008, 19 : 186 - 187
12345